SMALLCAPSDAILYNews / Catalysts / OpportunityGet the Daily Brief
Ticker HubNasdaq

ABOS

Acumen Pharmaceuticals, Inc. Common Stock

BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)Latest afterhours mover

Latest price

$0.2226-90.28%

As of Oct 30, 2026, 8:00 PM EDT · Market data by Massive

Market cap

$165.6M

Volume

68.1M

Previous close

$2.29

Day range

$0.2092 – $0.3520

Listed

Jul 1, 2021

Coverage

1 article

Price performance

Recent trading

5 trading days · 15-minute intervals · ET
$2.52$1.94$1.37$0.7886$0.2115Mon, 10/26Tue, 10/27Wed, 10/28Thu, 10/29Fri, 10/30
Five-day open $2.20Latest interval $0.2226

Newsroom

Latest ABOS coverage

After-hours movers roundup
Oct 30, 2026

After-Hours Movers: VCIG, YMAT, SLGB Lead the Small-Cap Scan

VCIG led a group of 7 active small-cap stocks flagged for editorial review.

VCIGYMATSLGBSGRX

Recent catalyst headlines

Acumen Pharmaceuticals Announces Topline Results from Phase 2 ALTITUDE-AD Clinical Trial of Sabirnetug (ACU193) for the Treatment of Early Alzheimer’s Disease; Trial Did Not Meet Primary Endpoint

Oct 30, 2026

Acumen Pharmaceuticals, Inc. Q3 2026 Earnings Call Summary

Oct 26, 2026

Acumen Pharmaceuticals (ABOS) Q3 2026 Earnings Call Transcript

Oct 26, 2026

Market data may be delayed and is provided for informational purposes only. SmallCapsDaily content is not investment advice.